Asimov Stock

HealthTech

Looking to sell Asimov stock or options?

Founded: 2017Funding to Date: $242M

Asimov, a developer of mammalian cell engineering software, aims to expedite the creation and production of gene therapies and biologics. The firm's platform unifies synthetic biology, machine learning-based design, and biophysical simulations to engineer genetic circuits in biotechnology. This allows healthcare institutions to streamline the design and printing of genetic logic gates, leading to the development of sophisticated therapeutics and manufacturing applications.

Investors include:

Further Key Investors:

Fidelity Investments, Casdin Capital, Wing Venture Capital, Pillar VC, Frog Design, Horizons Ventures, AME Cloud Ventures, CLF Partners, CPP Investments, KdT Ventures, DCVC.

Looking to sell Asimov Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you